Aubrey J Husak1, Matthew J Bair1,2,3. 1. Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana. 2. VA Health Services Research and Development Center for Health Information and Communication, Department of Veterans Affairs, Veterans Health Administration, Indianapolis, Indiana. 3. Regenstrief Institute, Inc., Indianapolis, Indiana, USA.
Abstract
OBJECTIVE: The objective of this review is to answer three questions: 1) How are chronic pain severity and pain duration affected in patients with chronic pain and sleep disturbances that occur simultaneously? 2) What are common comorbidities and pain-related symptoms seen in patients with chronic pain and sleep disturbances? and 3) What are potentially effective pharmacological and nonpharmacological treatment options for both conditions? METHODS: Ovid Medline and PubMed were searched. Search terms included sleep wake disorder, chronic pain, fibromyalgia, treatment outcome, psychotherapy, complementary therapies, and therapeutics. Studies that assessed outcomes between individuals with chronic pain and those with concurrent chronic pain and sleep disturbances were included. Randomized controlled clinical trials of treatments for both conditions were included. RESULTS: Sixteen studies indicated that patients with both chronic pain and sleep disturbances have greater pain severity, longer duration of pain, greater disability, and are less physically active than those without sleep disturbances. Patients with both conditions are more likely to have concurrent depression, catastrophizing, anxiety, and suicidal ideation. Thirty-three randomized controlled trials assessed treatment for both chronic pain and sleep disturbances. Pregabalin was the most frequently studied medication, showing improvement in pain and sleep symptoms. Cognitive behavioral therapy for insomnia showed long-term improvement in sleep for patients with chronic pain. CONCLUSIONS: Individuals with chronic pain and sleep disturbances have greater symptom severity, longer duration of symptoms, more disability, and additional comorbidities. Pharmacological and nonpharmacological treatments may be useful in the treatment of concurrent chronic pain and sleep disturbances, but further study is needed. 2020 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.
OBJECTIVE: The objective of this review is to answer three questions: 1) How are chronic pain severity and pain duration affected in patients with chronic pain and sleep disturbances that occur simultaneously? 2) What are common comorbidities and pain-related symptoms seen in patients with chronic pain and sleep disturbances? and 3) What are potentially effective pharmacological and nonpharmacological treatment options for both conditions? METHODS: Ovid Medline and PubMed were searched. Search terms included sleep wake disorder, chronic pain, fibromyalgia, treatment outcome, psychotherapy, complementary therapies, and therapeutics. Studies that assessed outcomes between individuals with chronic pain and those with concurrent chronic pain and sleep disturbances were included. Randomized controlled clinical trials of treatments for both conditions were included. RESULTS: Sixteen studies indicated that patients with both chronic pain and sleep disturbances have greater pain severity, longer duration of pain, greater disability, and are less physically active than those without sleep disturbances. Patients with both conditions are more likely to have concurrent depression, catastrophizing, anxiety, and suicidal ideation. Thirty-three randomized controlled trials assessed treatment for both chronic pain and sleep disturbances. Pregabalin was the most frequently studied medication, showing improvement in pain and sleep symptoms. Cognitive behavioral therapy for insomnia showed long-term improvement in sleep for patients with chronic pain. CONCLUSIONS: Individuals with chronic pain and sleep disturbances have greater symptom severity, longer duration of symptoms, more disability, and additional comorbidities. Pharmacological and nonpharmacological treatments may be useful in the treatment of concurrent chronic pain and sleep disturbances, but further study is needed. 2020 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.
Authors: Erica A Voss; Saberi Rana Ali; Arun Singh; Peter R Rijnbeek; Martijn J Schuemie; Daniel Fife Journal: Drug Saf Date: 2022-07-09 Impact factor: 5.228
Authors: Lliure-Naima Mory; Daniel de Oliveira Fernandes; Christian Mancini; Michael Mouthon; Joelle Nsimire Chabwine Journal: J Clin Med Date: 2022-06-08 Impact factor: 4.964
Authors: Olumuyiwa A Bamgbade; Jemima Tai-Osagbemi; Daniel O Bamgbade; Ofeoritse Murphy-Akpieyi; Abisola Fadire; Nikki K Soni; Lise Mumporeze Journal: J Clin Sleep Med Date: 2022-06-01 Impact factor: 4.324
Authors: Regina Wing Shan Sit; Benjamin Hon Kei Yip; Bo Wang; Dicken Cheong Chun Chan; Dexing Zhang; Samuel Yeung Shan Wong Journal: Sci Rep Date: 2021-01-15 Impact factor: 4.379